AIMP1 (Human, Recombinant)

CAT:
952-B2017305
Size:
100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
AIMP1 (Human, Recombinant) - image 1

AIMP1 (Human, Recombinant)

  • Description:

    AIMP1 (Human, Recombinant)_x000D_ Catalog number: B2017305_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 100 ug_x000D_ Molecular Weight or Concentration: 35 kDa_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: −80°C_x000D_ Keywords: Aminoacyl tRNA Synthase Complex-interacting Multifunctional Protein 1, EMAP-2, Endothelial Monocyte-activating Polypeptide 2, Multisynthase Complex Auxiliary Component p43, SCYE1, Small Inducible Cytokine Subfamily E Member 1_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Kolomiiets LA, Vorobyova NV, Lozhko DM, Zayets VM, Kornelyuk AI. Stabilization of AIMP1/p43 and EMAP II recombinant proteins in the complexes with polysaccharide dextran-70 Pharmacol Rep. 2020 Feb;72(1):238-245._x000D_ 2: Bottoni A, Vignali C, Piccin D, Tagliati F, Luchin A, Zatelli MC, Uberti EC. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines J Cell Physiol. 2007 Aug;212(2):293-7._x000D_ 3: Lee YS, Han JM, Kang T, Park YI, Kim HM, Kim S. Antitumor activity of the novel human cytokine AIMP1 in an in vivo tumor model Mol Cells. 2006 Apr 30;21(2):213-7._x000D_ 4: Ahn J, Kumar H, Cha BH, Park S, Arai Y, Han I, Park SG, Lee SH. AIMP1 downregulation restores chondrogenic characteristics of dedifferentiated/degenerated chondrocytes by enhancing TGF-β signal Cell Death Dis. 2016 Feb 18;7(2):e2099._x000D_ 5: Han JM, Myung H, Kim S. Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43) Cancer Lett. 2010 Jan 28;287(2):157-64._x000D_ 6: Hong SH, Cho JG, Yoon KJ, Lim DS, Kim CH, Lee SW, Park SG. The antibody atliximab attenuates collagen-induced arthritis by neutralizing AIMP1, an inflammatory cytokine that enhances osteoclastogenesis Biomaterials. 2015 Mar;44:45-54._x000D_ 7: Jackson VC, Dewilde S, Albo AG, Lis K, Corpillo D, Canepa B. The activity of aminoacyl-tRNA synthetase-interacting multi-functional protein 1 (AIMP1) on endothelial cells is mediated by the assembly of a cytoskeletal protein complex J Cell Biochem. 2011 Jul;112(7):1857-68._x000D_ 8: Zhou XL, Chen Y, Zeng QY, Ruan ZR, Fang P, Wang ED. Newly acquired N-terminal extension targets threonyl-tRNA synthetase-like protein into the multiple tRNA synthetase complex Nucleic Acids Res. 2019 Sep 19;47(16):8662-8674._x000D_ 9: Khan A, Bennett J, Scantlebury MH, Wei XC, Kerr M. AIMP1 Mutation Long-Term Follow-Up, With Decreased Brain N-Acetylaspartic Acid and Secondary Mitochondrial Abnormalities Child Neurol Open. 2019 Feb 21;6:2329048X19829520._x000D_ 10: Biancheri R, Rossi A, Zara F, Filocamo M. AIMP1/p43 mutation and PMLD Am J Hum Genet. 2011 Mar 11;88(3):391; author reply 393-5. _x000D_ _x000D_ Products Related to AIMP1 (Human, Recombinant) can be found at Proteins
  • Short Description:

    Catalog Number: B2017305 (100 µg)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5
  • CAS Number:

    9000-83-3